Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 150 articles:
HTML format



Single Articles


    December 2022
  1. HANRAHAN CF, Nonyane BAS, Lebina L, Mmolawa L, et al
    Household versus incentive-based contact investigation for tuberculosis in rural South Africa: a cluster-randomized trial.
    Clin Infect Dis. 2022 Dec 2:ciac920. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  2. SINHA P, Ponnuraja C, Gupte N, Babu SP, et al
    Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter Prospective Cohort Analysis.
    Clin Infect Dis. 2022 Nov 25:ciac915. doi: 10.1093.
    PubMed     Abstract available


  3. FLEXNER C, Siccardi M, Bunglawala F, Owen A, et al
    The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious Diseases.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  4. AMMERMAN NC, Nuermberger EL, Owen A, Rannard SP, et al
    Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  5. BROWN RIPIN DH, Catlin K, Lewis L, Resar D, et al
    Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  6. WILLIAMS CM, Muhammad AK, Sambou B, Bojang A, et al
    Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts.
    Clin Infect Dis. 2022 Nov 9. pii: 6815639. doi: 10.1093.
    PubMed     Abstract available


  7. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    PubMed     Abstract available


  8. NDEGE R, Ngome O, Vanobberghen F, Bani F, et al
    Ultrasound in managing extrapulmonary tuberculosis: A randomised, controlled, parallel, superiority, open-label trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6801068. doi: 10.1093.
    PubMed     Abstract available


  9. LOUIE JK, Keh C, Agraz-Lara R, Phillips A, et al
    Adverse Events Associated with Treatment for Pan-susceptible Tuberculosis in San Francisco.
    Clin Infect Dis. 2022 Nov 2. pii: 6793979. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  10. HEWISON C, Khan U, Bastard M, Lachenal N, et al
    Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
    Clin Infect Dis. 2022;75:1006-1013.
    PubMed     Abstract available


  11. KAIPILYAWAR V, Zhao Y, Wang X, Joseph NM, et al
    Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.
    Clin Infect Dis. 2022;75:1022-1030.
    PubMed     Abstract available


  12. EOM JS, Park S, Jang H, Kim S, et al
    Bronchial washing using a thin versus a thick bronchoscope to diagnose pulmonary tuberculosis: A randomized trial.
    Clin Infect Dis. 2022 Sep 24. pii: 6713550. doi: 10.1093.
    PubMed     Abstract available


  13. BALIASHVILI D, Blumberg HM, Benkeser D, Kempker RR, et al
    Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study.
    Clin Infect Dis. 2022 Sep 22. pii: 6711147. doi: 10.1093.
    PubMed     Abstract available


  14. HUANG HL, Lee JY, Lo YS, Liu IH, et al
    Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.
    Clin Infect Dis. 2022;75:743-752.
    PubMed     Abstract available


  15. KAY A, Reyes JM, Devezin T, Bakaya M, et al
    Optimal timing of antiretroviral therapy initiation in children and adolescents with HIV-associated pulmonary tuberculosis.
    Clin Infect Dis. 2022 Sep 13. pii: 6696609. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  16. PETTIT AC, Phillips PP, Kurbatova E, Vernon A, et al
    Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
    Clin Infect Dis. 2022 Aug 30. pii: 6679254. doi: 10.1093.
    PubMed     Abstract available


  17. KAGUJJE M, Kerkhoff AD, Nteeni M, Dunn I, et al
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis. 2022 Aug 25. pii: 6675069. doi: 10.1093.
    PubMed     Abstract available


  18. MARQUEZ C, Chen Y, Atukunda M, Chamie G, et al
    The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities.
    Clin Infect Dis. 2022 Aug 19. pii: 6671580. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  19. GASKELL KM, Pillay TD, Brown J, Belton M, et al
    Latent tuberculosis infection care.
    Clin Infect Dis. 2022 Jul 23. pii: 6649071. doi: 10.1093.
    PubMed    


  20. SANDS A, Santiago MT, Uduwana S, Glater-Welt L, et al
    Congenital Tuberculosis after In-vitro Fertilization: A Case for Tuberculosis Screening of Women Evaluated for Infertility.
    Clin Infect Dis. 2022 Jul 5. pii: 6629411. doi: 10.1093.
    PubMed     Abstract available


  21. PILLAY S, de Vos M, Derendinger B, Streicher E, et al
    Non-actionable results, accuracy and effect of the first- and second-line line probe assays for diagnosing drug resistant tuberculosis, including on smear-negative specimens, in a high-volume laboratory.
    Clin Infect Dis. 2022 Jul 5. pii: 6631215. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  22. PADMAPRIYADARSINI C, Vohra V, Bhatnagar A, Solanki R, et al
    Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
    Clin Infect Dis. 2022 Jun 29. pii: 6619622. doi: 10.1093.
    PubMed     Abstract available


  23. HEYSELL SK, Mpagama SG, Ogarkov OB, Conaway M, et al
    Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study.
    Clin Infect Dis. 2022 Jun 22. pii: 6613372. doi: 10.1093.
    PubMed     Abstract available


  24. MATHAD JS, Queiroz ATL, Bhosale R, Alexander M, et al
    Transcriptional analysis for tuberculosis in pregnant women from the PRACHITi study.
    Clin Infect Dis. 2022 Jun 10. pii: 6605083. doi: 10.1093.
    PubMed     Abstract available


  25. HORSBURGH CR, Jo Y, Nichols B, Jenkins HE, et al
    The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease.
    Clin Infect Dis. 2022 Jun 6. pii: 6603293. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  26. CHOI H, Han K, Jung JH, Park SH, et al
    Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study.
    Clin Infect Dis. 2022 May 25. pii: 6591843. doi: 10.1093.
    PubMed     Abstract available


  27. COX H, Workman L, Bateman L, Franckling-Smith Z, et al
    Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
    Clin Infect Dis. 2022 May 17. pii: 6586837. doi: 10.1093.
    PubMed     Abstract available


  28. LE V, Pascopella L, Westenhouse J, Barry P, et al
    A cross-sectional study of patients with extrapulmonary tuberculosis and normal chest radiographs - what characteristics were associated with sputum culture positivity?
    Clin Infect Dis. 2022 May 6. pii: 6581570. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  29. PODELL BK, Aibana O, Huang CC, DiLisio JE, et al
    The Impact of Vitamin A Deficiency on Tuberculosis Progression.
    Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
    PubMed     Abstract available


  30. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
    Correction to: Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa.
    Clin Infect Dis. 2022 Apr 27. pii: 6574994. doi: 10.1093.
    PubMed    


  31. CAMPBELL JR, Chan ED, Falzon D, Trajman A, et al
    Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
    PubMed     Abstract available


  32. HUGHES JA, Solans BP, Draper HR, Schaaf HS, et al
    Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2022 Apr 4. pii: 6563170. doi: 10.1093.
    PubMed     Abstract available


  33. HOLZMAN SB, Perry A, Saleeb P, Pyan A, et al
    Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.
    Clin Infect Dis. 2022 Apr 1. pii: 6562172. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  34. NATHELLA PK, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555776. doi: 10.1093.
    PubMed     Abstract available


  35. BATEMAN M, Wolf A, Chimukangara B, Brust JCM, et al
    Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in patients co-infected with HIV/AIDS and multidrug-resistant tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555759. doi: 10.1093.
    PubMed     Abstract available


  36. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    PubMed     Abstract available


  37. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
    High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
    Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
    PubMed     Abstract available


  38. PARADKAR MS, Devaleenal DB, Mvalo T, Arenivas A, et al
    Randomized Clinical Trial of High Dose Rifampicin with or without Levofloxacin versus Standard of Care for Paediatric Tuberculous Meningitis: The TBM-KIDS Trial.
    Clin Infect Dis. 2022 Mar 15. pii: 6549152. doi: 10.1093.
    PubMed     Abstract available


  39. NAIDOO K, Moodley MC, Hassan-Moosa R, Dookie N, et al
    Recurrent subclinical tuberculosis among ART accessing participants: Incidence, clinical course, and outcomes.
    Clin Infect Dis. 2022 Mar 5. pii: 6542969. doi: 10.1093.
    PubMed     Abstract available


  40. HUERGA H, Khan U, Bastard M, Mitnick CD, et al
    Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid and other second-line drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542212. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  41. SHRESTHA S, Winglee K, Hill A, Shaw T, et al
    Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas.
    Clin Infect Dis. 2022 Feb 10. pii: 6526443. doi: 10.1093.
    PubMed     Abstract available


  42. BERANGER A, Bekker A, Solans BP, Cotton MF, et al
    Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure.
    Clin Infect Dis. 2022 Feb 4. pii: 6522054. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  43. PALMER M, Gunasekera KS, van der Zalm MM, Morrison J, et al
    The diagnostic accuracy of chest radiographic features for pediatric intrathoracic tuberculosis.
    Clin Infect Dis. 2022 Jan 7. pii: 6500009. doi: 10.1093.
    PubMed     Abstract available


  44. MAVE V, Chen L, Ranganathan UD, Kadam D, et al
    Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
    Clin Infect Dis. 2022 Jan 4. pii: 6497515. doi: 10.1093/cid/ciab1067.
    PubMed     Abstract available


  45. STUCK L, van Haaster AC, Kapata-Chanda P, Klinkenberg E, et al
    How 'subclinical' is subclinical tuberculosis? An analysis of national prevalence survey data from Zambia.
    Clin Infect Dis. 2022 Jan 4. pii: 6497425. doi: 10.1093/cid/ciab1050.
    PubMed     Abstract available


    December 2021
  46. LI H, Chee CBE, Geng T, Pan A, et al
    Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study.
    Clin Infect Dis. 2021 Dec 27. pii: 6484917. doi: 10.1093.
    PubMed     Abstract available


  47. MARTINSON NA, Lebina L, Webb EL, Ratsela A, et al
    Household contact tracing with intensified tuberculosis and HIV screening in South Africa: a cluster randomised trial.
    Clin Infect Dis. 2021 Dec 24. pii: 6482200. doi: 10.1093/cid/ciab1047.
    PubMed     Abstract available


  48. KHALIFE S, Jenkins HE, Dolynska M, Terleieva I, et al
    Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data.
    Clin Infect Dis. 2021 Dec 20. pii: 6470933. doi: 10.1093/cid/ciab1018.
    PubMed     Abstract available


  49. PODANY AT, Pham M, Sizemore E, Martinson N, et al
    Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine.
    Clin Infect Dis. 2021 Dec 16. pii: 6464327. doi: 10.1093/cid/ciab1037.
    PubMed     Abstract available


  50. SINHA P, Lakshminarayanan SL, Cintron C, Narasimhan PB, et al
    Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) model.
    Clin Infect Dis. 2021 Dec 15. pii: 6462896. doi: 10.1093/cid/ciab1033.
    PubMed     Abstract available


  51. GAFAR F, Marais BJ, Nataprawira HM, Alffenaar JC, et al
    Optimizing antimicrobial and host-directed therapies to improve clinical outcomes of childhood tuberculous meningitis.
    Clin Infect Dis. 2021 Dec 15. pii: 6463307. doi: 10.1093/cid/ciab1036.
    PubMed    


  52. HAMILTON CD
    Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing.
    Clin Infect Dis. 2021;73:e3937-e3938.
    PubMed    


  53. MOED S, Suprenant M, Odjidja EN, Meguid T, et al
    Economic Evaluation of Screening Interventions for Drug-induced Liver Injury.
    Clin Infect Dis. 2021;73:e3959-e3965.
    PubMed     Abstract available


  54. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
    Prevalence of Mycobacterium tuberculosis in sputum and reported symptoms among clinic attendees compared to a community survey in rural South Africa.
    Clin Infect Dis. 2021 Dec 3. pii: 6433207. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  55. KEMPKER RR, Smith AGC, Avaliani T, Gujabidze M, et al
    Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
    Clin Infect Dis. 2021 Nov 29. pii: 6446239. doi: 10.1093.
    PubMed     Abstract available


  56. THEE S, Basu Roy R, Blazquez-Gamero D, Falcon-Neyra L, et al
    Treatment and outcome in children with tuberculous meningitis - a multi-centre Paediatric Tuberculosis Network European Trials Group study.
    Clin Infect Dis. 2021 Nov 27. pii: 6444805. doi: 10.1093.
    PubMed     Abstract available


  57. PADMAPRIYDARSINI C, Mamulwar M, Mohan A, Shanmugam P, et al
    Randomized trial of Metformin with Anti-tuberculosis drugs For Early Sputum Conversion in Adults with Pulmonary Tuberculosis.
    Clin Infect Dis. 2021 Nov 26. pii: 6444297. doi: 10.1093.
    PubMed     Abstract available


  58. VELEN K, Nhung NV, Anh NT, Cuong PD, et al
    Risk Factors for Tuberculosis (TB) Among Household Contacts of Patients With Smear-Positive TB in 8 Provinces of Vietnam: A Nested Case-Control Study.
    Clin Infect Dis. 2021;73:e3358-e3364.
    PubMed     Abstract available


  59. DAS M, Dalal A, Laxmeshwar C, Ravi S, et al
    One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
    Clin Infect Dis. 2021;73:e3496-e3504.
    PubMed     Abstract available


  60. HALEY C, Rowlinson MC, Ashkin D
    Tuberculosis Therapy: "In Pursuit of Perfection".
    Clin Infect Dis. 2021;73:e3529-e3530.
    PubMed    


    October 2021
  61. DOS SANTOS PCP, da Silva Santos A, de Oliveira RD, da Silva BO, et al
    Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons.
    Clin Infect Dis. 2021 Oct 28. pii: 6413467. doi: 10.1093.
    PubMed     Abstract available


  62. KUMAR GS, Pezzi C, Payton C, Mamo B, et al
    Health of Asylees Compared to Refugees in the United States Using Domestic Medical Examination Data, 2014-2016: A Cross-Sectional Analysis.
    Clin Infect Dis. 2021;73:1492-1499.
    PubMed     Abstract available


  63. DENTI P, Wasmann RE, van Rie A, Winckler J, et al
    Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study.
    Clin Infect Dis. 2021 Oct 19. pii: 6403131. doi: 10.1093.
    PubMed     Abstract available


  64. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed     Abstract available


  65. MACLEAN E, Dendukuri N
    Latent Class Analysis and the Need for Clear Reporting of Methods.
    Clin Infect Dis. 2021;73:e2285-e2286.
    PubMed    


  66. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
    Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  67. SUTHERLAND JS, van der Spuy G, Gindeh A, Thuong NT, et al
    Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results.
    Clin Infect Dis. 2021 Sep 22. pii: 6373967. doi: 10.1093.
    PubMed     Abstract available


  68. OLOMI W, Biraro IA, Kilonzo K, Te Brake L, et al
    Tuberculosis preventive therapy for people with diabetes mellitus.
    Clin Infect Dis. 2021 Sep 10. pii: 6368159. doi: 10.1093.
    PubMed    


  69. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38+CD27-TNF-alpha + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Clin Infect Dis. 2021;73:793-801.
    PubMed     Abstract available


    August 2021
  70. MARTINEZ L, Ncayiyana JR, Goddard L, Botha M, et al
    Vitamin D concentrations in infancy and the risk of tuberculosis in childhood: A prospective birth cohort in Cape Town, South Africa.
    Clin Infect Dis. 2021 Aug 26. pii: 6358095. doi: 10.1093.
    PubMed     Abstract available


  71. NWONGBOUWOH MUEFONG C, Owolabi O, Donkor S, Charalambous S, et al
    Neutrophils contribute to severity of tuberculosis pathology and recovery from lung damage pre- and post-treatment.
    Clin Infect Dis. 2021 Aug 24. pii: 6356988. doi: 10.1093.
    PubMed     Abstract available


  72. CHABALA C, Turkova A, Hesseling AC, Zimba KM, et al
    Pharmacokinetics of first-line drugs in children with tuberculosis using WHO-recommended weight band doses and formulations.
    Clin Infect Dis. 2021 Aug 22. pii: 6356214. doi: 10.1093.
    PubMed     Abstract available


  73. FRITSCHI N, Wind A, Hammer J, Ritz N, et al
    Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study.
    Clin Infect Dis. 2021 Aug 19. pii: 6354867. doi: 10.1093.
    PubMed     Abstract available


  74. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    PubMed     Abstract available


  75. BURKE RM, Gupta Wright A
    Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
    Clin Infect Dis. 2021;73:e878-e879.
    PubMed    


  76. MATOGA MM, Bisson GP, Gupta A, Miyahara S, et al
    Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
    Clin Infect Dis. 2021;73:e870-e877.
    PubMed     Abstract available


  77. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
    Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
    Clin Infect Dis. 2021;73:706-715.
    PubMed     Abstract available


    July 2021
  78. KIM S, Cohen T, Horsburgh CR, Miller JW, et al
    Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.
    Clin Infect Dis. 2021 Jul 29. pii: 6330597. doi: 10.1093.
    PubMed     Abstract available


  79. MATHAD JS, Savic R, Britto P, Jayachandran P, et al
    Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
    Clin Infect Dis. 2021 Jul 29. pii: 6330598. doi: 10.1093.
    PubMed     Abstract available


  80. MOODLEY N, Velen K, Saimen A, Zakhura N, et al
    Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.
    Clin Infect Dis. 2021 Jul 27. pii: 6329140. doi: 10.1093.
    PubMed     Abstract available


  81. KAY AW, Sandoval M, Mtetwa G, Mkhabela M, et al
    Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting.
    Clin Infect Dis. 2021 Jul 24. pii: 6327779. doi: 10.1093.
    PubMed     Abstract available


  82. RADTKE KK, Hesseling AC, Winckler JL, Draper HR, et al
    Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children.
    Clin Infect Dis. 2021 Jul 21. pii: 6324883. doi: 10.1093.
    PubMed     Abstract available


  83. TAVAZIVA G, Harris M, Abidi SK, Geric C, et al
    Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy.
    Clin Infect Dis. 2021 Jul 21. pii: 6324830. doi: 10.1093.
    PubMed     Abstract available


  84. WEIR IR, Wasserman S
    Treatment effect measures for culture conversion endpoints in phase IIb tuberculosis treatment trials.
    Clin Infect Dis. 2021 Jul 13. pii: 6319902. doi: 10.1093.
    PubMed     Abstract available


  85. PEETLUK LS, Rebeiro PF, Ridolfi FM, Andrade BB, et al
    A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes.
    Clin Infect Dis. 2021 Jul 2. pii: 6313211. doi: 10.1093.
    PubMed     Abstract available


  86. BAIK Y, Hanrahan CF, Mmolawa L, Nonyane BAS, et al
    Conditional cash transfers to incentivize tuberculosis screening: Description of a novel strategy for contact investigation in rural South Africa.
    Clin Infect Dis. 2021 Jul 2. pii: 6312933. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  87. CHU AL, Murray MB, Huang CC
    Potential role of latent tuberculosis infection in the pathophysiology of cardiovascular disease.
    Clin Infect Dis. 2021 Jun 28. pii: 6310818. doi: 10.1093.
    PubMed    


  88. CEGIELSKI JP, Udwadia ZF, Viiklepp P, Yim JJ, et al
    Reply to van Deun and Decroo.
    Clin Infect Dis. 2021;72:e1168-e1169.
    PubMed    


  89. CHIDAMBARAM V, Tun NL, Majella MG, Ruelas Castillo J, et al
    Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis.
    Clin Infect Dis. 2021 Jun 8. pii: 6294896. doi: 10.1093.
    PubMed     Abstract available


  90. LU P, Liu Q, Zhou Y, Martinez L, et al
    Predictors of Discordant Tuberculin Skin Test and QuantiFERON-TB Gold In-tube Results in Eastern China: A Population-based, Cohort Study.
    Clin Infect Dis. 2021;72:2006-2015.
    PubMed     Abstract available


    May 2021
  91. CHU AL, Lecca LW, Calderon RI, Contreras CC, et al
    Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts.
    Clin Infect Dis. 2021 May 28. pii: 6287936. doi: 10.1093.
    PubMed     Abstract available


  92. XU M, Lu W, Li T, Li J, et al
    Sensitivity, specificity, and safety of a novel ESAT6-CFP10 skin test for tuberculosis infection in China: two randomized, self-controlled, parallel-group phase 2b trials.
    Clin Infect Dis. 2021 May 22. pii: 6280234. doi: 10.1093.
    PubMed     Abstract available


  93. LEE H, Myung W, Lee EM, Kim H, et al
    Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study.
    Clin Infect Dis. 2021;72:e610-e619.
    PubMed     Abstract available


  94. MALIK AA, Becerra MC, Lash TL, Cranmer LM, et al
    Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.
    Clin Infect Dis. 2021;72:1709-1715.
    PubMed     Abstract available


  95. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    PubMed    


  96. MARAIS BJ
    Improved Urine Lipoarabinomannan (LAM) Tests: The Answer for Child Tuberculosis Diagnosis?
    Clin Infect Dis. 2021;72:e289-e290.
    PubMed    


    April 2021
  97. GROBBEL HP, Merker M, Kohler N, Andres S, et al
    Design of multidrug-resistant tuberculosis treatment regimens based on DNA sequencing.
    Clin Infect Dis. 2021 Apr 26. pii: 6253713. doi: 10.1093.
    PubMed     Abstract available


  98. BRUST JCM, Gandhi NR, Wasserman S, Maartens G, et al
    Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study.
    Clin Infect Dis. 2021 Apr 21. pii: 6244470. doi: 10.1093.
    PubMed     Abstract available


  99. HWANG H, Kang H, Kwon YS, Jeon D, et al
    Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
    Clin Infect Dis. 2021 Apr 10. pii: 6219782. doi: 10.1093.
    PubMed     Abstract available


  100. MARAIS BJ
    Good Outcomes in Babies With In Utero Bedaquiline Exposure.
    Clin Infect Dis. 2021;72:1169-1170.
    PubMed    


    March 2021
  101. BALIASHVILI D, Gandhi NR, Kim S, Hughes M, et al
    Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.
    Clin Infect Dis. 2021 Mar 27. pii: 6193424. doi: 10.1093.
    PubMed     Abstract available


  102. ADU-GYAMFI C, Savulescu D, Mikhathani L, Otwombe K, et al
    Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women.
    Clin Infect Dis. 2021 Mar 15. pii: 6170938. doi: 10.1093.
    PubMed     Abstract available


  103. CRESSWELL FV, Meya DB, Kagimu E, Grint D, et al
    High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly HIV-positive Ugandan adults: a phase II open-label randomised controlled trial.
    Clin Infect Dis. 2021 Mar 8. pii: 6159697. doi: 10.1093.
    PubMed     Abstract available


  104. HUANG HL, Huang WC, Lin KD, Liu SS, et al
    Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients with Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.
    Clin Infect Dis. 2021 Mar 3. pii: 6157057. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  105. BURKE RM, Gupta Wright A
    Diagnosing tuberculosis in people with advanced HIV: more is needed.
    Clin Infect Dis. 2021 Feb 26. pii: 6152006. doi: 10.1093.
    PubMed    


  106. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38 +CD27 -TNF-alpha + on Mtb-specific CD4 + T is a robust biomarker for tuberculosis diagnosis.
    Clin Infect Dis. 2021 Feb 19. pii: 6144985. doi: 10.1093.
    PubMed     Abstract available


  107. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
    The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
    Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
    PubMed     Abstract available


  108. DU PREEZ K, Osman M, Seddon JA, Naidoo P, et al
    The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents.
    Clin Infect Dis. 2021 Feb 3. pii: 6127007. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  109. GUNASEKERA KS, Walters E, van der Zalm MM, Palmer M, et al
    Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis.
    Clin Infect Dis. 2021 Jan 15. pii: 6101512. doi: 10.1093.
    PubMed     Abstract available


  110. BROGER T, Nicol MP
    A novel bedside rule-in test for tuberculous meningitis in HIV-infected adults.
    Clin Infect Dis. 2021 Jan 6. pii: 6065103. doi: 10.1093/cid/ciaa1915.
    PubMed    


  111. HUAMAN MA, De Cecco CN, Bittencourt MS, Ticona E, et al
    Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
    Clin Infect Dis. 2021 Jan 3. pii: 6060062. doi: 10.1093/cid/ciaa1934.
    PubMed     Abstract available


  112. QUINN CM, Kagimu E, Okirworth M, Bangdiwala AS, et al
    Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in HIV-infected adults.
    Clin Infect Dis. 2021 Jan 3. pii: 6059780. doi: 10.1093/cid/ciaa1910.
    PubMed     Abstract available


    December 2020
  113. TACK I, Dumicho A, Ohler L, Shigayeva A, et al
    Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
    Clin Infect Dis. 2020 Dec 29. pii: 6054965. doi: 10.1093/cid/ciaa1894.
    PubMed     Abstract available


  114. VAN DEUN A, Decroo T
    How second-line injectable drugs work.
    Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
    PubMed    


  115. YUEN CM, Majidulla A, Jaswal M, Safdar N, et al
    Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting.
    Clin Infect Dis. 2020 Dec 8. pii: 6025518. doi: 10.1093/cid/ciaa1835.
    PubMed     Abstract available


  116. OH CE, Ortiz-Brizuela E, Bastos ML, Menzies D, et al
    Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2020 Dec 8. pii: 6026460. doi: 10.1093/cid/ciaa1822.
    PubMed     Abstract available


  117. DONOVAN J, Oanh PKN, Dobbs N, Phu NH, et al
    Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis.
    Clin Infect Dis. 2020 Dec 7. pii: 6025000. doi: 10.1093/cid/ciaa1823.
    PubMed     Abstract available


  118. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed     Abstract available


  119. WONG EB
    It is time to focus on asymptomatic tuberculosis.
    Clin Infect Dis. 2020 Dec 6. pii: 6024996. doi: 10.1093/cid/ciaa1827.
    PubMed    


  120. VAN TOORN R, Solomons RS, Seddon JA, Schoeman JF, et al
    Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort.
    Clin Infect Dis. 2020 Dec 6. pii: 6024997. doi: 10.1093/cid/ciaa1826.
    PubMed     Abstract available


    November 2020
  121. ASABOR EN, Vermund SH
    Confronting structural racism in the prevention and control of tuberculosis in the United States.
    Clin Infect Dis. 2020 Nov 26. pii: 6006871. doi: 10.1093/cid/ciaa1763.
    PubMed     Abstract available


  122. HUANG HL, Lee MR, Cheng MH, Lu PL, et al
    Impact of age on outcome of rifapentine-based weekly therapy for latent tuberculosis infection.
    Clin Infect Dis. 2020 Nov 19. pii: 5992466. doi: 10.1093/cid/ciaa1741.
    PubMed     Abstract available


  123. REDDY KP, Denkinger CM, Broger T, McCann NC, et al
    Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with HIV.
    Clin Infect Dis. 2020 Nov 17. pii: 5983890. doi: 10.1093/cid/ciaa1698.
    PubMed     Abstract available


  124. MONTEPIEDRA G, Kim S, Weinberg A, Theron G, et al
    Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women.
    Clin Infect Dis. 2020 Nov 4. pii: 5955952. doi: 10.1093/cid/ciaa1674.
    PubMed     Abstract available


  125. COLLINS JM, Stout JE, Ayers T, Hill AN, et al
    Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017.
    Clin Infect Dis. 2020 Nov 2. pii: 5952274. doi: 10.1093/cid/ciaa1662.
    PubMed     Abstract available


    October 2020
  126. CEGIELSKI JP, Chan PC, Lan Z, Udwadia ZF, et al
    Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.
    Clin Infect Dis. 2020 Oct 30. pii: 5943503. doi: 10.1093.
    PubMed     Abstract available


  127. ZHENG X, Bao Z, Forsman LD, Hu Y, et al
    Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response.
    Clin Infect Dis. 2020 Oct 18. pii: 5929670. doi: 10.1093/cid/ciaa1569.
    PubMed     Abstract available


  128. KAKAIRE R, Kiwanuka N, Zalwango S, Sekandi JN, et al
    Excess Risk of Tuberculous Infection among Extra-Household Contacts of Tuberculosis Cases in an African City.
    Clin Infect Dis. 2020 Oct 16. pii: 5925052. doi: 10.1093/cid/ciaa1556.
    PubMed     Abstract available


  129. DUFFY D, Nemes E, Llibre A, Rouilly V, et al
    Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.
    Clin Infect Dis. 2020 Oct 16. pii: 5924452. doi: 10.1093/cid/ciaa1562.
    PubMed     Abstract available


  130. ZELNICK JR, Daftary A, Hwang C, Labar AS, et al
    Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV.
    Clin Infect Dis. 2020 Oct 14. pii: 5923372. doi: 10.1093/cid/ciaa1557.
    PubMed     Abstract available


  131. KUHLIN J, Davies Forsman L, Mansjo M, Jonsson Nordvall M, et al
    Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis.
    Clin Infect Dis. 2020 Oct 3. pii: 5917759. doi: 10.1093/cid/ciaa1509.
    PubMed     Abstract available


    September 2020
  132. THERON G, Montepiedra G, Aaron L, McCarthy K, et al
    Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV.
    Clin Infect Dis. 2020 Sep 30. pii: 5913421. doi: 10.1093/cid/ciaa1482.
    PubMed     Abstract available


  133. MARTYN EM, Bangdiwala AS, Kagimu E, Rutakingirwa MK, et al
    Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis.
    Clin Infect Dis. 2020 Sep 28. pii: 5912549. doi: 10.1093/cid/ciaa1444.
    PubMed     Abstract available


    July 2020
  134. MIRANDA C, Bark CM
    TB, or not TB, the Choice Is Ours.
    Clin Infect Dis. 2020;71:291-292.
    PubMed    


  135. BOLD TD, Cheng MP, Marty FM
    Reply to Singh.
    Clin Infect Dis. 2020;71:471-472.
    PubMed    


    June 2020
  136. JIANG Q, Liu Q, Ji L, Li J, et al
    Citywide Transmission of Multidrug-resistant Tuberculosis Under China's Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study.
    Clin Infect Dis. 2020;71:142-151.
    PubMed     Abstract available


  137. DONOVAN J, Cresswell FV, Thuong NTT, Boulware DR, et al
    Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
    Clin Infect Dis. 2020 Jun 16. pii: 5858077. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  138. HORSBURGH CR
    "Plus Ca Change...".
    Clin Infect Dis. 2020;70:2119-2120.
    PubMed    


    April 2020
  139. HERMANS SM, Zinyakatira N, Caldwell J, Cobelens FGJ, et al
    High rates of recurrent TB disease: a population-level cohort study.
    Clin Infect Dis. 2020 Apr 25. pii: 5825249. doi: 10.1093.
    PubMed     Abstract available


  140. ALFFENAAR JC, Gumbo T, Dooley KE, Peloquin CA, et al
    Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.
    Clin Infect Dis. 2020;70:1774-1780.
    PubMed     Abstract available


    March 2020
  141. CHENG MP, Marty FM
    Reply to Aronson et al.
    Clin Infect Dis. 2020;70:1262.
    PubMed    


    February 2020
  142. VAN DER WERF MJ, Rosales-Klintz S, de Vlas SJ
    Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
    Clin Infect Dis. 2020;70:716-717.
    PubMed    


  143. MIYAHARA S, Ramchandani R, Kim S, Evans SR, et al
    Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
    Clin Infect Dis. 2020;70:698-703.
    PubMed     Abstract available


    January 2020
  144. UGARTE-GIL C, Pearson F, Moore D, Critchley J, et al
    Reply to Yates and Barr.
    Clin Infect Dis. 2020;70:545-546.
    PubMed    


  145. HONG H, Dowdy DW
    Reply to Chen, Song, and Liu.
    Clin Infect Dis. 2020;70:547-548.
    PubMed    


  146. CHEN HL, Song YP, Liu K
    Prediction Model Needs More Improvements Before Clinical Application.
    Clin Infect Dis. 2020;70:546-547.
    PubMed    


    November 2019
  147. MANABE YC, Andrade BB, Gupte N, Leong S, et al
    A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident TB and Mortality in Advanced HIV.
    Clin Infect Dis. 2019 Nov 25. pii: 5639757. doi: 10.1093/cid/ciz1147.
    PubMed     Abstract available


    September 2019
  148. MNGQIBISA R, Kendall MA, Dooley K, Wu X, et al
    Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency.
    Clin Infect Dis. 2019 Sep 5. pii: 5561543. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  149. RAVIMOHAN S, Auld SC, Maenetje P, Ratsela N, et al
    Lung injury on antiretroviral therapy in adults with HIV/TB.
    Clin Infect Dis. 2019 Jun 26. pii: 5523721. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  150. THAO LTP, Wolbers M, Heemskerk AD, Thi Hoang Mai N, et al
    Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements.
    Clin Infect Dis. 2019 Apr 4. pii: 5427068. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: